I have absolutely no idea when the first deal will be..
my opinion it will be soon, your opinion is after dx3 is further tested and clinical phase 1 trail commences….
if your opinion is correct then imho PAB will be under 1c and pretty ducked for the longer term…
if the dr cannot licence out dx3 well before trails that means big pharma are not happy and we will have to go it alone and will be heavily diluted and smashed to go through the trials alone….
Deals will come soon or even the run up to clinic will be painful….
Dr Campbell will get us a rerating soon enough then hopefully we can hear some positives from you instead of just baiting with no content
email the Dr like I do, he is saying some really good stuff with huge “transformational” possibilities happening soon
Looking forward to the next 12 months with great excitement., page-92
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $10.97K | 3.626M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 31554019 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 27089307 | 15 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |